全文获取类型
收费全文 | 3082篇 |
免费 | 285篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 165篇 |
妇产科学 | 53篇 |
基础医学 | 336篇 |
口腔科学 | 48篇 |
临床医学 | 269篇 |
内科学 | 658篇 |
皮肤病学 | 86篇 |
神经病学 | 172篇 |
特种医学 | 318篇 |
外科学 | 407篇 |
综合类 | 93篇 |
一般理论 | 1篇 |
预防医学 | 291篇 |
眼科学 | 63篇 |
药学 | 229篇 |
1篇 | |
中国医学 | 8篇 |
肿瘤学 | 150篇 |
出版年
2021年 | 35篇 |
2020年 | 23篇 |
2019年 | 27篇 |
2018年 | 38篇 |
2017年 | 25篇 |
2016年 | 33篇 |
2015年 | 41篇 |
2014年 | 56篇 |
2013年 | 65篇 |
2012年 | 108篇 |
2011年 | 127篇 |
2010年 | 71篇 |
2009年 | 60篇 |
2008年 | 110篇 |
2007年 | 121篇 |
2006年 | 115篇 |
2005年 | 104篇 |
2004年 | 96篇 |
2003年 | 125篇 |
2002年 | 124篇 |
2001年 | 100篇 |
2000年 | 107篇 |
1999年 | 93篇 |
1998年 | 71篇 |
1997年 | 58篇 |
1996年 | 67篇 |
1995年 | 76篇 |
1994年 | 69篇 |
1993年 | 69篇 |
1992年 | 68篇 |
1991年 | 66篇 |
1990年 | 63篇 |
1989年 | 88篇 |
1988年 | 77篇 |
1987年 | 71篇 |
1986年 | 86篇 |
1985年 | 76篇 |
1984年 | 57篇 |
1983年 | 42篇 |
1982年 | 43篇 |
1981年 | 29篇 |
1980年 | 37篇 |
1979年 | 54篇 |
1978年 | 43篇 |
1977年 | 37篇 |
1976年 | 22篇 |
1975年 | 35篇 |
1974年 | 17篇 |
1973年 | 20篇 |
1972年 | 12篇 |
排序方式: 共有3386条查询结果,搜索用时 15 毫秒
1.
2.
AIM: To assess the efficacy of intravesical botulinum toxin type A (BTX-A) in interstitial cystitis (IC). METHODS: Eleven patients with IC were injected with BTX-A. Primary outcome measures were: Bristol Female Lower Urinary Tract Symptom Score, Kings Health Questionnaire and 24-hour frequency-volume chart. They had urodynamics done before and six weeks after injection. Detrusor contractility was assessed using the modified PIP1 (projected isovolumetric detrusor pressure). 相似文献
3.
An in-vitro study of the interactions between intravenous induction agents and the calcium antagonists verapamil and nifedipine 总被引:1,自引:0,他引:1
Thiopentone, propofol and etomidate inhibit the contractions of the rat isolated atria and portal vein. The actions of thiopentone and propofol summate with those of verapamil and nifedipine. Verapamil potentiates the action of etomidate on both preparations. The depressant actions of thiopentone and propofol on the portal vein are associated with a reduced response to calcium. Etomidate does not reduce the response to calcium in this preparation. 相似文献
4.
5.
A H Filipovich D Vallera P McGlave D Polich K Gajl-Peczalska R Haake L Lasky B Blazar N K Ramsay J Kersey 《Transplantation》1990,50(3):410-415
Twenty-nine patients with advanced leukemias (median age 34 years) received histocompatible sibling marrow that had been depleted of T cells by ex vivo incubation with anti-CD5 monoclonal antibody-ricin immunotoxin (T101-R) for the purpose of graft-versus-host disease prophylaxis. Donor cell engraftment was documented in 28/29 patients by DNA restriction fragment length polymorphisms. In this pilot study the dose of T101-R incubated with donor marrow was increased in a stepwise manner from 300 ng (10 patients) to 600 ng (5 patients) to 1000 ng immunotoxin (IT)/10(7) bone marrow mononuclear cells (14 patients) in an attempt to achieve more effective GvHD prophylaxis. A statistically significant reduction in acute GvHD was achieved for patients receiving marrow pretreated with 1000 ng of immunotoxin (34%) compared to recipients of BM treated with 300 ng immunotoxin (100%, P = 0.0004). T-depleted marrow samples were evaluated for residual T cell activity using several in vitro assays including proliferation to the purified mitogen PHA (HA-17) and in mixed lymphocyte culture (MLC), T cell cytotoxicity, a limiting dilution assay for detecting precursors of proliferating T cells (LDApPTL), and phenotypic analysis of viable T cells expanded in 16-day culture with interleukin 2. The extent of T cell depletion determined by LDA assay varied widely at each immunotoxin concentration used. Thus, there was no correlation between the dose of T cells infused and subsequent GvHD. Phenotyping of lymphocytes recovered from immunotoxin-treated marrow demonstrated that residual T cells were CD5 negative in all cases tested. The only in vitro parameter that predicted subsequent acute or chronic GvHD was the demonstration of viable CD5 negative lymphocytes with T cell phenotype (CD2, CD3, and/or CD7 positive) after 16-day culture with IL-2 of the T-depleted bone marrow. We observed that such CD5 negative cells expressing other T cell markers have cytotoxic function and speculate that these cells may be capable of mediating GvHD in allogeneic transplantation. 相似文献
6.
RAFAEL BEYAR M.D. D.Sc. ARIEL ROGUIN M.D. JAAP HAMBURGER M.D. RE SAAIMAN M.D. ANTONIO L. BARTORELLI M.D. CARLO DiMARIO M.D. ANTONIO COLOMBO M.D. CHRISTIAN W. HAMM M.D. CHRISTOPHER J. WHITE M.D. J. MARCO M.D. PATRICK W. SERRUYS M.D. Ph.D. 《Journal of interventional cardiology》1997,10(4):277-286
The beStent is a new stainless steel, balloon-expandable mesh stent which has a unique serpentine design. Rotation of the unique low stress junctions upon expansion leads to orthogonal locking of the wires, maximizing radial strength and assuring zero shortening. The stent has delineating gold markers which assure precise positioning. We aim to present the initial acute results in a pilot registry for stent evaluation. Two hundred eighty-four stents were used in a total of 217 patients (age 57.9 ± 3.10 years; 178 males; 39 females) in seven centers, for variable indications. Stents of 15-, 25-, and 35-mm length were used. The arteries treated were the left anterior descending (n = 112, 42%), circumflex (n = 54, 20.2%), right coronary (n = 95, 35.5%), left main (n = 1, 0.4%), and vein graft (n = 5, 1.9%). Lesion types were: A in 42 patients (16.5%); B1 in 53 patients (20.7%); B2 in 81 patients (31.8%); and C in 79 patients (31%). One hundred fifty-nine patients required one stent, 40 patients required two stents, and 18 patients required three or more stents. Anticoagulation protocol included procedural heparin with aspirin with/without ticlopidine. Smooth angiographie results were obtained in all cases with no plaque herniation. Acute angiographic success was obtained in 97% of the patients, and acute clinical success in 95% of the patients. Complications within 30 days were: 3 deaths (1.4%) (2 noncardiac); 2 (0.9%) myocardial infarctions; and 2 (0.9%) stent thromboses. Therefore, the beStent is useful in treatment of complex lesions of variable length and complexity, providing excellent acute results with a low complication rate, in spite of unfavorable basic clinical and angiographie characteristics. 相似文献
7.
8.
Laser Treatment of Endobronchial Lesions 总被引:2,自引:0,他引:2
9.
10.
We studied 11 cases of malignant lymphoma diagnosed concurrently with or following lymph node infarction. Cases included seven B-cell lymphomas, three T-cell lymphomas, and one case of Hodgkin's disease. Sections of viable and infarcted tissue were immunostained in parallel using a panel of antibodies effective in routinely processed, wax-embedded tissue. The panel included anti-leucocyte-common antigen (CD45), T-cell-associated antigens (UCHL1, MT1), B-cell-associated antigens (MB1, 4KB5 (CD45R), MT2, LN1), a B-cell-specific antigen (L26), C3D-1 (CD15), and BER-H2 (CD30). Antibodies to intermediate filament cytoskeletal proteins, epithelial membrane antigen, and Factor VIII-related antigen were also used. In eight cases, staining of the infarcted material gave evidence of a lymphoid proliferation of either T- or B-cell type; an in the case of Hodgkin's disease, the results supported this diagnosis. The immunophenotype derived in the infarcted tissue mirrored the findings in the viable material in these eight cases of non-Hodgkin's lymphoma. A case of testicular infarction with concurrent intraosseous lymphoma was also examined. Staining in this case provided evidence of infarcted lymphoma. Thus, immunostaining of infarcted lymphoid tissue with these novel antibodies provides valuable information that conventional light microscopy cannot offer. 相似文献